Critical information on the comparative performance of several regulatory requirement-compliant cell lines for isolation of influenza viruses from clinical species for subsequent use as candidate vaccine viruses is not available. In additionIn addition, it would be important to determine whether isolation of viruses in a given cell line could have a detrimental impact on antigen yields in different cell lines used by other manufacturer